Call for Abstract

16th International Conference on Neurology and Neuro Cognitive Disorders, will be organized around the theme “Breakthroughs and Achievements in Neurocognitive Research”

Neurocognitive Disorders 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Neurocognitive Disorders 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Cognitive psychology
  • Track 1-2Neuropsychology
  • Track 1-3Neurobiology
  • Track 1-4Experimental Psychology
  • Track 1-5Physiological psychology
  • Track 1-6Cognitive genomics

Neurocognitive disorders are characterized by decline from an attained level of cognitive functioning mainly when physical changes can be seen to have occurred in brain, such as after neurological and mental illness, drug use, or brain injury. Neurocognitive disorders involve impairments in cognitive abilities such as memory, problem solving, and perception. Neurocognitive disorders (NCDs) are a category of conditions that include dementia, amnesia, Mild cognitive impairment, Attention deficit hyperactive disorder. 

  • Track 2-1Sleep disorders
  • Track 2-2Mild Cognitive Impairment
  • Track 2-3Attention Deficit Hyperactive Disorder
  • Track 2-4Hallucinogen Persisting Perception Disorder
  • Track 2-5Amnestic Disorder
  • Track 2-6Cerebellar Cognitive Affective Syndrome
  • Track 2-7Post Operative Cognitive Dysfunction
  • Track 2-8HIV-associated Neurocognitive Disorder
  • Track 2-9HIV-associated neurocognitive disorder
  • Track 3-1Lewy Body Dementia
  • Track 3-2Frontotemporal Dementia
  • Track 3-3Huntingtons Disease
  • Track 3-4Normal Pressure Hydrocephalus
  • Track 3-5Parkinsons Disease
  • Track 3-6Wernicke-Korsakoff Syndrome
  • Track 4-1Stroke related Dementia
  • Track 4-2Post-stroke Dementia
  • Track 4-3Single Infarct and Multi Infarct Dementia
  • Track 4-4Sub Cortical Dementia
  • Track 4-5Mixed Dementia
  • Track 5-1Mild Cognitive Impairment
  • Track 5-2Vascular Cognitive Impairment
  • Track 5-3Cognitive Impairment in Multiple Scleriosis
  • Track 5-4Pathophysiology of Dementia
  • Track 6-1Schizophrenic and Delusion Disorders
  • Track 6-2Delirium
  • Track 6-3Amnesia
  • Track 6-4Disorders of Personality
  • Track 6-5Brain tumour
  • Track 6-6Brain Damage and Organic Disease
  • Track 6-7Alcohol Misuse and Dependency
  • Track 7-1Alzheimers Disease
  • Track 7-2Alzheimers disease
  • Track 7-3Amylotropic Lateral Sclerosis
  • Track 7-4Batten Disease
  • Track 7-5Huntingtons disease
  • Track 8-1Neuropsychiatric Disorders
  • Track 8-2Organic Psychosis
  • Track 8-3Mood Disorders
  • Track 8-4Behavioural Neurology
  • Track 9-1Addivitive Neural Dynamic Model
  • Track 9-2Real Time Robot Path
  • Track 9-3Manipulating Neural Dynamics by using TMS and EEG Recordings
  • Track 10-1Neurosurgery
  • Track 10-2Pediatric Neurosurgery
  • Track 10-3Brain and spinal cord injury
  • Track 10-4spine surgery
  • Track 10-5Clinical Nursing
  • Track 10-6Cancer Nursing
  • Track 10-7Healthcare Nursing
  • Track 10-8Nursing Management
  • Track 11-1Nursing Management
  • Track 11-2Standard Therapy
  • Track 11-3Reality Orientation
  • Track 11-4Validation Therapy
  • Track 11-5Cognitive Behaviour Therapy
  • Track 11-6Alternative Therapy
  • Track 12-1Recent Drug Development
  • Track 12-2Psychopharmaceuticals
  • Track 12-3Psychopharmacology
  • Track 12-4Neuroimmuno Pharmacology
  • Track 12-5Molecular Neuropharmacology

It is an older term for the treatment of disorders that affect the nervous system which psychological, psychiatric, and nervous disorders. Neurotherapeutics is a quarterly peer-reviewed medical journal covering research on experimental treatments of neurological disorders. It includes Stem cells and treatment, Nerve injury and repair Clinical Case report, Neurogenesis, cell and gene based approach and Neurotransmitter release and cell repair.       

  • Track 13-1Neuropharmacological studies
  • Track 13-2Novel treatments for Neurological Diseases
  • Track 13-3Stimulation Techniques
  • Track 13-4Cellular and Biochemical methods
  • Track 13-5Novel Diagnostic Methods and Tools
  • Track 13-6Advanced Neuroloy Devices and Equipments